INVESTABOT
Equity Research
XNYS · TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-09-29. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
TL;DR: Verizon's Board of Directors elected Charles Phillips, Co-Founder and Managing Partner of Recognize Partners LP, as a director effective September 25, 2026.
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-09-22. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-09-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-08-25. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-08-18. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
TL;DR: Verizon filed an officer change disclosure on July 24, 2026, but the filing does not identify the executive involved by name or title. Without those details, the scope of the change remains unclear.
Verizon Communications (VZ) had 1 Form 144 pre-sale notice filed on 2026-05-29. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 2 unique sellers · 4 accumulating - 9 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 29, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | SELL | -1,100 | $46 | ~$51K |
| September 25, 2026 | Phillips Jr Charles E | — | GRANT | 1,770 | — | — |
| September 24, 2026 | Schulman Daniel H | CEO | GRANT | 197.03 | $14 | ~$3K |
| September 24, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | GRANT | 128.7 | $14 | ~$2K |
| September 24, 2026 | Russo Joseph J. | EVP&Pres-Global Networks&Tech | GRANT | 81.72 | $14 | ~$1K |
| September 24, 2026 | Skiadas Anthony T | EVP and CFO | GRANT | 128.7 | $14 | ~$2K |
| September 24, 2026 | Stillwell Mary-Lee | SVP and Controller | GRANT | 43.28 | $14 | ~$1K |
| September 24, 2026 | Venkatesh Vandana | EVP and Chief Legal Officer | GRANT | 94.53 | $14 | ~$1K |
| September 24, 2026 | Villanueva Rodriguez Alfonso | EVP and Group CEO-VZ Consumer | GRANT | 128.7 | $14 | ~$2K |
| September 22, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | SELL | -1,100 | $48 | ~$52K |
| September 15, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | SELL | -1,100 | $51 | ~$56K |
| September 10, 2026 | Schulman Daniel H | CEO | GRANT | 186.64 | $14 | ~$3K |
| September 10, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | GRANT | 121.91 | $14 | ~$2K |
| September 10, 2026 | Russo Joseph J. | EVP&Pres-Global Networks&Tech | GRANT | 77.41 | $14 | ~$1K |
| September 10, 2026 | Skiadas Anthony T | EVP and CFO | GRANT | 121.91 | $14 | ~$2K |
| September 10, 2026 | Stillwell Mary-Lee | SVP and Controller | GRANT | 41 | $14 | ~$1K |
| September 10, 2026 | Venkatesh Vandana | EVP and Chief Legal Officer | GRANT | 89.55 | $14 | ~$1K |
| September 10, 2026 | Villanueva Rodriguez Alfonso | EVP and Group CEO-VZ Consumer | GRANT | 252.99 | $14 | ~$4K |
| September 8, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | SELL | -1,100 | $50 | ~$55K |
| September 1, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | SELL | -1,100 | $51 | ~$56K |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| September 29, 2026 | Malady Kyle | — | 1,100 | SEC |
| September 22, 2026 | Malady Kyle | — | 1,100 | SEC |
| September 15, 2026 | Malady Kyle | — | 1,100 | SEC |
| September 8, 2026 | Malady Kyle | — | 1,100 | SEC |
| September 1, 2026 | Malady Kyle | — | 1,100 | SEC |
| August 25, 2026 | Malady Kyle | — | 1,100 | SEC |
| August 18, 2026 | Malady Kyle | — | 1,100 | SEC |
| May 29, 2026 | Hammock Samantha | — | 73,069 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| September 29, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 368,027,599 | ~$18.5B | -0.3% | May 13, 2026 |
| BlackRock | 400,805,658 | ~$17.0B | 8.9% | August 7, 2026 |
| Vanguard Group | 379,402,347 | ~$15.5B | — | January 29, 2026 |
| BlackRock | 369,056,692 | ~$15.0B | — | February 12, 2026 |
| BlackRock | 348,871,645 | ~$14.4B | — | August 13, 2024 |
| State Street | 214,853,728 | ~$10.8B | -3.6% | May 15, 2026 |
| State Street | 222,951,399 | ~$9.1B | — | February 13, 2026 |
| State Street | 209,676,274 | ~$8.9B | -2.4% | August 7, 2026 |
| Morgan Stanley | 74,068,170 | ~$3.7B | 14.0% | May 15, 2026 |
| Morgan Stanley | 70,302,870 | ~$3.0B | -5.1% | August 13, 2026 |
| Morgan Stanley | 64,997,318 | ~$2.6B | — | May 27, 2026 |
| Goldman Sachs | 39,444,661 | ~$2.0B | 24.9% | May 15, 2026 |
| JP Morgan Chase | 42,543,648 | ~$1.9B | 15.6% | August 12, 2026 |
| JP Morgan Chase | 36,812,819 | ~$1.9B | 17.4% | May 13, 2026 |
| Goldman Sachs | 39,239,828 | ~$1.7B | -0.5% | August 14, 2026 |
| Fidelity (FMR) | 31,169,574 | ~$1.6B | 7.2% | May 15, 2026 |
| Goldman Sachs | 31,571,552 | ~$1.3B | — | March 25, 2026 |
| JP Morgan Chase | 31,368,268 | ~$1.3B | — | February 11, 2026 |
| Fidelity (FMR) | 29,086,902 | ~$1.2B | — | February 17, 2026 |
| Fidelity (FMR) | 25,976,622 | ~$1.1B | -16.7% | August 13, 2026 |